as of 12-05-2025 3:59pm EST
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 2.1B | IPO Year: | 2019 |
| Target Price: | $27.25 | AVG Volume (30 days): | 1.8M |
| Analyst Decision: | Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.62 | EPS Growth: | 2.96 |
| 52 Week Low/High: | $13.86 - $27.51 | Next Earning Date: | 11-06-2025 |
| Revenue: | $1,268,689,000 | Revenue Growth: | 11.41% |
| Revenue Growth (this year): | 11.55% | Revenue Growth (next year): | 9.52% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
CHIEF FINANCIAL OFFICER
Avg Cost/Share
$25.50
Shares
213
Total Value
$5,431.50
Owned After
47,921
SEC Form 4
EVP, GC
Avg Cost/Share
$26.87
Shares
2,398
Total Value
$64,434.26
Owned After
73,657
SEC Form 4
CHIEF FINANCIAL OFFICER
Avg Cost/Share
$25.50
Shares
21,303
Total Value
$543,226.50
Owned After
47,921
SEC Form 4
CHIEF EXECUTIVE OFFICER
Avg Cost/Share
$24.29
Shares
79,500
Total Value
$1,930,896.00
Owned After
680,251
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Livingston Mark S. | PGNY | CHIEF FINANCIAL OFFICER | Dec 2, 2025 | Sell | $25.50 | 213 | $5,431.50 | 47,921 | |
| Swartz Allison | PGNY | EVP, GC | Nov 28, 2025 | Sell | $26.87 | 2,398 | $64,434.26 | 73,657 | |
| Livingston Mark S. | PGNY | CHIEF FINANCIAL OFFICER | Nov 17, 2025 | Sell | $25.50 | 21,303 | $543,226.50 | 47,921 | |
| Anevski Peter | PGNY | CHIEF EXECUTIVE OFFICER | Nov 13, 2025 | Buy | $24.29 | 79,500 | $1,930,896.00 | 680,251 |
See how PGNY stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "PGNY Progyny Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.